In an ideal world, every cancer patient would get a completely personalized treatment that can serve their individual needs and requirements, but alas, doctors are only human, and giving that kind treatment for every cancer patient simply isn’t feasible. However, it could be feasible with the help of an artificially intelligent supercomputer like IBM’s Watson.
Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp’s Watson computer system to choose therapies based on a tumor’s genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients. Oncology is the first specialty where matching therapy to DNA has improved outcomes for some patients, inspiring the “precision medicine initiative” President Barack Obama announced in January. But it can take weeks to identify drugs targeting cancer-causing mutations. Watson can do it in minutes and has in its database the findings of scientific papers and clinical trials on particular cancers and potential therapies. Faced with such a data deluge, “the solution is going to be Watson or something like it,” said oncologist Norman Sharpless of the University of North Carolina Lineberger Cancer Center. “Humans alone can’t do it.”
TECHi weighs both sides before reaching a conclusion.
NOTE: TECHi Two-Takes are the stories we have chosen from the web along with a little bit of our opinion in a paragraph. Please check the original story in the Source Button below.
Japanese video game maker Nintendo will develop a device to measure a user's fatigue and map their sleep, Chief Executive…
Not having free Wi-Fi at a resort or hotel can be considered to be a First World Problem, and in…
LG is continuing to push OLED TV technology with the announcement that it'll be the first company in the world…
Landing the car-sized Curiosity rover on Mars was difficult enough, but what about when you want to go bigger? What…
